+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Forecast 2024-2030- Product Image
Global In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Forecast 2024-2030- Product Image
Sale

Global In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5137193
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In Situ Hybridization Market size was estimated at USD 1.81 billion in 2023, USD 1.94 billion in 2024, and is expected to grow at a CAGR of 7.92% to reach USD 3.10 billion by 2030.

In-situ hybridization is a process utilized to identify and detect specific DNA sequences in cells with an increasing number of unknown viruses. In-situ hybridization allows precise localization of a specific nucleic acid segment within a histologic section. It is a major laboratory technique used to localize an RNA or DNA sequence in a biological sample. The prevalence of chronic diseases and the need for rapid diagnostic techniques contribute to the increasing adoption of in-situ hybridization. Cancer was among the leading cause of death in 2020, with approximately 100 million deaths worldwide. Growing demand for molecular diagnostic tools and advancements in the field of IVD is anticipated to boost the adoption of in-situ hybridization (ISH) technology in the coming years. High costs and limited skilled professionals for managing in-situ hybridization hamper the adoption of in-situ hybridization. However, the ongoing technological advancements and increasing research and development (R&D) to introduce innovative in-situ hybridizations are expected to create opportunities for the growth of the in-situ hybridization market.

Regional Insights

The presence of technologically upgraded infrastructure in the U.S., Canada, and Brazil is increasing the adoption of ISH, which enables early diagnosis of diseases. Furthermore, key players in the In Situ Hybridization (ISH) market and the launch of innovative products in the region are expected to fuel the In Situ Hybridization (ISH) industry growth in the Americas. In December 2022, OmicsVeu launched an extensive line of spatial biology products, mRNA and DNA FISH probes, and kits. A wide range of over 220 plus fluorophore-tagged miRNA probes enables the generation of multiplex miRNA profiling. Increasing investments in R&D pertaining to IVD in Europe driving the adoption of in situ hybridization (ISH) market. The presence of government organizations in the region, including the European Diagnostic Manufacturers Association (EDMA), which focuses on the development and overall growth of the European IVD industry, is contributing to the growth of the ISH market in Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Situ Hybridization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Situ Hybridization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Situ Hybridization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Abnova Corporation, Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Bio-Rad Laboratories, Inc., Biocare Medical, LLC, BioCat GmbH, Bioevopeak Co., Ltd. |, BioGenex Laboratories, Biomers.net GmbH, BioView Ltd., Cell Line Genetics, Inc., CellCarta Biosciences Inc., Charles River Laboratories International, Inc., CiteAb Ltd., Cole-Parmer Instrument Company, LLC., Creative Bioarray, Creative Biolabs, Daicel Arbor Biosciences, DSS Imagetech Pvt. Ltd., Emsurg Healthcare (India) Pvt. Limited, Enzo Life Sciences, Inc., Excilone, F. Hoffmann-La Roche Ltd, Flogentec, GeneDetect.com Limited, Intertek Group PLC, KromaTiD Inc., Leica Biosystems Nussloch GmbH, Merck KGaA, Molecular Instruments, Inc., NeoGenomics Laboratories, Inc., Okabé Bureau, Opgen, Oxford Gene Technology IP Limited, PerkinElmer Inc., Qiagen N.V., QIMA Life Sciences, Reveal Biosciences, Inc., Ribocon GmbH, Spatial Genomics, Inc., Stratech Scientific Ltd, Suraksha Diagnostic Private Limited, Thermo Fisher Scientific Inc., Vector Laboratories, Inc., Zytomed Systems GmbH, and ZytoVision GmbH.

Market Segmentation & Coverage

This research report categorizes the In Situ Hybridization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Accessories
      • Kits & Reagents
      • Probes
    • Instruments
    • Software
  • Technology
    • Chromogenic In Situ Hybridization
    • Fluorescence In Situ Hybridization
      • DNA Fluorescence In Situ Hybridization
      • PNA Fluorescence In Situ Hybridization
      • RNA Fluorescence In Situ Hybridization
  • Application
    • Cancer Diagnostics
    • Cytology
    • Immunology
    • Infectious Disease Diagnostics
    • Neuroscience
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospital & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the In Situ Hybridization Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Situ Hybridization Market?
  3. What are the technology trends and regulatory frameworks in the In Situ Hybridization Market?
  4. What is the market share of the leading vendors in the In Situ Hybridization Market?
  5. Which modes and strategic moves are suitable for entering the In Situ Hybridization Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. In Situ Hybridization Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of infectious diseases demanding rapid diagnostic techniques
5.1.1.2. Rising inclination towards molecular diagnostic tools
5.1.1.3. Increasing investments in R&D pertaining to IVD
5.1.2. Restraints
5.1.2.1. Limitation in identifying the low DNA and RNA sequencing
5.1.3. Opportunities
5.1.3.1. Rapid advent of 3D fluorescence in situ hybridization (FISH) technologies
5.1.3.2. Technological advancements and strategic investments to develop ISH technologies
5.1.4. Challenges
5.1.4.1. Concerns regarding lack of skilled professionals to provide proper diagnosis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. In Situ Hybridization Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Accessories
6.3.2. Kits & Reagents
6.3.3. Probes
6.3. Instruments
6.4. Software
7. In Situ Hybridization Market, by Technology
7.1. Introduction
7.2. Chromogenic In Situ Hybridization
7.3. Fluorescence In Situ Hybridization
7.4.1. DNA Fluorescence In Situ Hybridization
7.4.2. PNA Fluorescence In Situ Hybridization
7.4.3. RNA Fluorescence In Situ Hybridization
8. In Situ Hybridization Market, by Application
8.1. Introduction
8.2. Cancer Diagnostics
8.3. Cytology
8.4. Immunology
8.5. Infectious Disease Diagnostics
8.6. Neuroscience
9. In Situ Hybridization Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospital & Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies
10. Americas In Situ Hybridization Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific In Situ Hybridization Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa In Situ Hybridization Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Biocare Medical Acquires Empire Genomics | Precision Oncology News
13.3.1.2. Danaher To Acquire Aldevron
13.3.1.3. PNI to be Acquired by Danaher Corporation’s Life Sciences Platform
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Avacta Announces Distribution Agreement With ABCAM plc | Business Wire
13.3.3. New Product Launch & Enhancement
13.3.3.1. Bio-Techne has announced the commercial release of novel DNAscope in situ hybridization assays
13.3.4. Investment & Funding
13.3.4.1. Resolve Biosciences Raises $71M in Series B Financing
13.3.5. Award, Recognition, & Expansion
13.3.5.1. FDA approves Roche’s Ventana ALK (D5F3) CDx Assay for lung cancer
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam Plc
14.1.3. Abnova Corporation
14.1.4. Advanced Cell Diagnostics, Inc.
14.1.5. Agilent Technologies, Inc.
14.1.6. Bio SB
14.1.7. Bio-Rad Laboratories, Inc.
14.1.8. Biocare Medical, LLC
14.1.9. BioCat GmbH
14.1.10. Bioevopeak Co., Ltd. |
14.1.11. BioGenex Laboratories
14.1.12. Biomers.net GmbH
14.1.13. BioView Ltd.
14.1.14. Cell Line Genetics, Inc.
14.1.15. CellCarta Biosciences Inc.
14.1.16. Charles River Laboratories International, Inc.
14.1.17. CiteAb Ltd.
14.1.18. Cole-Parmer Instrument Company, LLC.
14.1.19. Creative Bioarray
14.1.20. Creative Biolabs
14.1.21. Daicel Arbor Biosciences
14.1.22. DSS Imagetech Pvt. Ltd.
14.1.23. Emsurg Healthcare (India) Pvt. Limited
14.1.24. Enzo Life Sciences, Inc.
14.1.25. Excilone
14.1.26. F. Hoffmann-La Roche Ltd
14.1.27. Flogentec
14.1.28. GeneDetect.com Limited
14.1.29. Intertek Group PLC
14.1.30. KromaTiD Inc.
14.1.31. Leica Biosystems Nussloch GmbH
14.1.32. Merck KGaA
14.1.33. Molecular Instruments, Inc.
14.1.34. NeoGenomics Laboratories, Inc.
14.1.35. Okabé Bureau
14.1.36. Opgen
14.1.37. Oxford Gene Technology IP Limited
14.1.38. PerkinElmer Inc.
14.1.39. Qiagen N.V.
14.1.40. QIMA Life Sciences
14.1.41. Reveal Biosciences, Inc.
14.1.42. Ribocon GmbH
14.1.43. Spatial Genomics, Inc.
14.1.44. Stratech Scientific Ltd
14.1.45. Suraksha Diagnostic Private Limited
14.1.46. Thermo Fisher Scientific Inc.
14.1.47. Vector Laboratories, Inc.
14.1.48. Zytomed Systems GmbH
14.1.49. ZytoVision GmbH
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. IN SITU HYBRIDIZATION MARKET RESEARCH PROCESS
FIGURE 2. IN SITU HYBRIDIZATION MARKET SIZE, 2022 VS 2030
FIGURE 3. IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. IN SITU HYBRIDIZATION MARKET DYNAMICS
FIGURE 7. IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 14. IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. IN SITU HYBRIDIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. IN SITU HYBRIDIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 8. IN SITU HYBRIDIZATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IN SITU HYBRIDIZATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IN SITU HYBRIDIZATION MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IN SITU HYBRIDIZATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IN SITU HYBRIDIZATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 14. IN SITU HYBRIDIZATION MARKET SIZE, BY CHROMOGENIC IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 17. IN SITU HYBRIDIZATION MARKET SIZE, BY DNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IN SITU HYBRIDIZATION MARKET SIZE, BY PNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IN SITU HYBRIDIZATION MARKET SIZE, BY RNA FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. IN SITU HYBRIDIZATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IN SITU HYBRIDIZATION MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IN SITU HYBRIDIZATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IN SITU HYBRIDIZATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. IN SITU HYBRIDIZATION MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. IN SITU HYBRIDIZATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. IN SITU HYBRIDIZATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. IN SITU HYBRIDIZATION MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. IN SITU HYBRIDIZATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 52. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 58. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES IN SITU HYBRIDIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 84. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 86. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CHINA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 90. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 92. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. INDIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 102. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 104. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. JAPAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 138. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. THAILAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 157. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 159. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. DENMARK IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 163. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 165. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 169. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FINLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 177. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FRANCE IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 183. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 193. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 195. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. ITALY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NORWAY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 217. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. POLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 223. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 225. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. QATAR IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 247. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 249. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SPAIN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 265. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 267. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. TURKEY IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM IN SITU HYBRIDIZATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. IN SITU HYBRIDIZATION MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 282. IN SITU HYBRIDIZATION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 283. IN SITU HYBRIDIZATION MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Abcam Plc
  • Abnova Corporation
  • Advanced Cell Diagnostics, Inc.
  • Agilent Technologies, Inc.
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • BioCat GmbH
  • Bioevopeak Co., Ltd. |
  • BioGenex Laboratories
  • Biomers.net GmbH
  • BioView Ltd.
  • Cell Line Genetics, Inc.
  • CellCarta Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • CiteAb Ltd.
  • Cole-Parmer Instrument Company, LLC.
  • Creative Bioarray
  • Creative Biolabs
  • Daicel Arbor Biosciences
  • DSS Imagetech Pvt. Ltd.
  • Emsurg Healthcare (India) Pvt. Limited
  • Enzo Life Sciences, Inc.
  • Excilone
  • F. Hoffmann-La Roche Ltd
  • Flogentec
  • GeneDetect.com Limited
  • Intertek Group PLC
  • KromaTiD Inc.
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • Molecular Instruments, Inc.
  • NeoGenomics Laboratories, Inc.
  • Okabé Bureau
  • Opgen
  • Oxford Gene Technology IP Limited
  • PerkinElmer Inc.
  • Qiagen N.V.
  • QIMA Life Sciences
  • Reveal Biosciences, Inc.
  • Ribocon GmbH
  • Spatial Genomics, Inc.
  • Stratech Scientific Ltd
  • Suraksha Diagnostic Private Limited
  • Thermo Fisher Scientific Inc.
  • Vector Laboratories, Inc.
  • Zytomed Systems GmbH
  • ZytoVision GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.94 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.1 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Fluorescence In-Situ Hybridization Imaging Systems Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography - Product Image

Fluorescence In-Situ Hybridization Imaging Systems Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

  • Report
  • 212 Pages
  • Global
From
Global In Situ Hybridization Market Size, Share & Trends Analysis Report by Technology (FISH, CISH), Probe Type (DNA, RNA), Product (Instrument, Consumables & Accessories, Software, Services), Application, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global In Situ Hybridization Market Size, Share & Trends Analysis Report by Technology (FISH, CISH), Probe Type (DNA, RNA), Product (Instrument, Consumables & Accessories, Software, Services), Application, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global In Situ Hybridization Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global In Situ Hybridization Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 183 Pages
  • Global
From
In Situ Hybridization (ISH) - Global Strategic Business Report - Product Image

In Situ Hybridization (ISH) - Global Strategic Business Report

  • Report
  • 504 Pages
  • Global
From
Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the In Situ Hybridization Market

In Situ Hybridization (ISH) is a molecular diagnostic technique used to detect and localize specific nucleic acid sequences within cells and tissues. It is used to detect gene expression, chromosomal abnormalities, and gene mutations. ISH is a powerful tool for diagnosing diseases such as cancer, genetic disorders, and infectious diseases. ISH involves the use of labeled probes, which are complementary to the target nucleic acid sequence. The probes are hybridized to the target sequence, and the labeled probes are detected using a variety of techniques, such as fluorescence microscopy, immunohistochemistry, and in situ PCR. ISH is used in a variety of clinical applications, including the diagnosis of cancer, genetic disorders, and infectious diseases. It is also used in research to study gene expression, chromosomal abnormalities, and gene mutations. Companies in the In Situ Hybridization market include Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.